Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Vitro Quality Assessment of Myogenic Stem Cells in Multiple Patient Groups With Confirmed Skeletal Muscle Atrophy to Study Their Potential for Autologous Stem Cell Therapy

NCT06077734 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT06077734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06077734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Vitro Quality Assessment of Myogenic Stem Cells in Multiple Patient Groups With Confirmed Skeletal Muscle Atrophy to Study Their Potential for Autologous Stem Cell Therapy
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Terminated
Start date
November 27, 2023
Completion date
February 16, 2026
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrophy, muscle, cachexia, mesenchymal stem cells, muscle weakness, sarcopenia, stem cell transplantation